Filtros de búsqueda

Lista de obras de Camillo Porta

'TUNEL' evidence of reduced bone marrow cells apoptosis in a refractory anaemia patient treated with amifostine

artículo científico publicado en 1999

3rd Pavia international symposium on advanced kidney cancer.

artículo científico publicado en 2012

5-Fluorouracil and d,l-leucovorin calcium are active to treat unresectable hepatocellular carcinoma patients: preliminary results of a phase II study

artículo científico publicado en 1995

5-Fluorouracil combined with the pure L-stereoisomer of leukovorin calcium to treat advanced colon-cancer patients - a phase-ii study

artículo científico publicado en 1995

5-methyltetrahydrofolate or 5-formyltetrahydrofolic acid to modulate 5-fluorouracil's cytotoxic activity in vivo. A phase II study in patients with advanced colon cancer

artículo científico publicado en 1996

A new patient-focused approach to the treatment of metastatic renal cell carcinoma: establishing customized treatment options

artículo científico publicado en 2010

A pooled analysis of sequential therapies with sorafenib and sunitinib in metastatic renal cell carcinoma.

artículo científico publicado en 2012

A rapid D-dimer assay in patients presenting at the emergency room with suspected acute venous thrombosis: accuracy and relation to clinical variables

artículo científico publicado en 2001

A retrospective analysis of two different sequences of therapy lines for advanced kidney cancer.

artículo científico publicado en 2013

Acute promyelocytic leukaemia (APL): chemotherapy or bone marrow transplantation?

artículo científico publicado en 1989

Adding raltitrexed to cisplatin improves overall survival in people with malignant pleural mesothelioma

artículo científico publicado en 2006

Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): a phase III, randomized, multicentre trial of the Italian Oncology Group for Clinical Research (GOIRC).

artículo científico publicado en 2014

Adjuvant treatment for resected renal cell carcinoma: are all strategies equally negative? Potential implications for trial design with targeted agents.

artículo científico publicado en 2013

Adverse event management in patients with advanced cancer receiving oral everolimus: focus on breast cancer

artículo científico publicado en 2014

Allopurinol mouthwashes in methotrexate-induced stomatitis

scientific article published on 01 May 1994

Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas

scientific article published on 01 December 1998

Amifostine (WR-2721, Ethyol(TM)) can protect human endothelial but not tumor cells from cisplatin-induced cytotoxicity

artículo científico publicado en 1997

Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF

artículo científico publicado en 2000

An Anti-MICA/B Antibody and IL-15 Rescue Altered NKG2D-Dependent NK Cell Responses in Hepatocellular Carcinoma

scientific article published on 30 November 2020

An evaluation of UGN-101, a sustained-release hydrogel polymer-based formulation containing mitomycin-C, for the treatment of upper urothelial carcinomas

artículo científico publicado en 2020

Angiogenesis inhibitor therapies for advanced renal cell carcinoma: toxicity and treatment patterns in clinical practice from a global medical chart review

artículo científico publicado en 2013

Anti-HCV antibodies and hepatocellular carcinoma. Relationship in a medium-risk population

artículo científico publicado en 1992

Antioxidant enzymatic system and free radicals pathway in two different human cancer cell lines

artículo científico publicado en 1996

Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP.

artículo científico publicado en 1997

Application of "omics" sciences to the prediction of bone metastases from breast cancer: State of the art

scientific article published on 05 November 2020

Assessing the impact of evolving evidence in renal cell carcinoma treatment: an update of the Renal Cell Carcinoma Appropriateness-based Treatment Toolkit (ReCATT).

artículo científico publicado en 2014

Atrial septal aneurysm in a patient with pseudoxanthoma elasticum

scientific article published on 01 January 1998

Autoimmunity in thrombotic thrombocytopenic purpura

artículo científico publicado en 2005

Axitinib dose titration: what's the limiting factor?

artículo científico publicado en 2013

BBR 3438, a novel 9-aza-anthrapyrazole, in patients with advanced gastric cancer: A phase II study group trial of the central European Society of Anticancer-Drug Research (CESAR)

article published in 2005

Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions

scientific article published on 27 October 2020

Benign idiopathic hypereosinophilia: a feeble masquerader or a smouldering form of the hypereosinophilic syndrome?

artículo científico publicado en 1995

Bevacizumab plus interferon-α versus sunitinib for first-line treatment of renal cell carcinoma in Italy: a cost-minimization analysis

artículo científico publicado en 2011

Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?

artículo científico publicado en 2015

Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma.

artículo científico publicado en 2007

Case report: long-lasting response in a patient with metastatic renal cell cancer receiving antitumor cytotoxic T lymphocytes.

artículo científico publicado en 2013

Catheter seeding of hepatocellular carcinoma following placement of a total implantable access port system

artículo científico publicado en 1998

Cationic protein-rich supernatants of cultured eosinophils from IL-2-treated patients have no cytotoxic activity on human renal cell carcinoma and melanoma cells: a preliminary report

artículo científico publicado en 1997

Changes in circulating pro-angiogenic cytokines, other than VEGF, before progression to sunitinib therapy in advanced renal cell carcinoma patients

artículo científico publicado en 2012

Chemotherapy with or without low-dose interleukin-2 in advanced non-small cell lung cancer: results from a phase III randomized multicentric trial.

artículo científico publicado en 2011

Chronic Epstein-Barr virus infection

artículo científico publicado en 1992

Chronic myeloid leukemia following cyclophosphamide-containing chemotherapy in a breast cancer patient

artículo científico publicado en 1993

Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma.

artículo científico publicado en 2007

Circulating progenitor cell release and functional characterization after topotecan plus G-CSF and erythropoietin in small cell lung cancer patients

scientific article published on 01 October 1999

Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site : results of an Italian multicenter, randomized, phase II study

artículo científico publicado en 2006

Cisplatin, mitomycin-C, 5-fluorouracil and leucovorin combination chemotherapy (l-FCM) in locally advanced unresectable or metastatic gastric carcinoma: a phase-II study.

artículo científico publicado en 2001

Colon cancer in pregnancy: report of a case and review of the literature.

artículo científico publicado en 2000

Combination or sequencing strategies to improve the outcome of metastatic renal cell carcinoma patients: a critical review

artículo científico publicado en 2011

Comparing comparators: a look at control arms in kidney cancer studies over the years.

artículo científico publicado en 2014

Concurrent intra-arterial carboplatin administration and radiation therapy for the treatment of advanced head and neck squamous cell carcinoma: short term results

scientific article published on 04 September 2009

Considerations for the design of future clinical trials in metastatic renal cell carcinoma

artículo científico publicado en 2013

Correlation between the grade of histological malignancy and nuclear positivity using the AgNOR technique in 6 cases of isolated bone NHL

artículo científico publicado en 1992

Could interferon still play a role in metastatic renal cell carcinoma? A randomized study of two schedules of sorafenib plus interferon-alpha 2a (RAPSODY).

artículo científico publicado en 2012

Cytokine-based immunotherapy for advanced kidney cancer: past results and future perspectives in the era of molecularly targeted agents.

artículo científico publicado en 2007

Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins

artículo científico publicado en 2004

Determination of free and total (free plus protein-bound) melatonin in plasma and cerebrospinal fluid by high-performance liquid chromatography with fluorescence detection

artículo científico publicado en 2002

Dovitinib (CHIR258, TKI258): structure, development and preclinical and clinical activity

artículo científico publicado en 2015

Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial.

artículo científico

Doxorubicin/methotrexate/fluorouracil in advanced pancreatic cancer

artículo científico publicado en 1990

Editorial debate: Challenges an oncologist has to face during the SARS-CoV-2 pandemic within a universal healthcare system

scientific article published on 01 May 2020

Effect of different platelet agonists on intracellular free Ca++ concentrations in human tumor cells: possible role in tumor growth

artículo científico publicado en 1995

Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 Trial.

artículo científico publicado en 2012

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial

artículo científico publicado en 2012

Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET.

artículo científico publicado en 2009

Endodermal sinus tumor of the ovary in pregnancy

artículo científico publicado en 1997

Endothelin-1 and 5-fluorouracil-induced cardiotoxicity.

artículo científico publicado en 1998

Entropy Increases in Kidney Cancer Treatment, but a Bit of Simplicity May Emerge From Chaos ⬇️

artículo científico publicado el 2 de agosto de 2011

Eosinophils and C4 predict clinical failure of combination immunotherapy with very low dose subcutaneous interleukin-2 and interferon in renal cell carcinoma patients

artículo científico publicado en 2000

Eosinophils and serum eosinophilic cationic proteins in interleukin-2-based immunotherapy for cancer

scientific article published on 01 March 1998

Epirubicin and etoposide combination chemotherapy to treat hepatocellular carcinoma patients: a phase II study

scientific article published on 01 October 1997

Erionite and asbestos differently cause transformation of human mesothelial cells

artículo científico publicado en 2007

Evaluation of treatment options for patients with advanced renal cell carcinoma: assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodology

artículo científico publicado en 2012

Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: a RECORD-1 subgroup analysis

artículo científico publicado en 2012

Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study.

artículo científico publicado en 2011

Experience gathered from retrospective series on renal cell carcinoma is useful, but now it is time for a global claim for academically driven prospective studies.

artículo científico publicado en 2012

Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment.

artículo científico publicado en 2015

Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases

artículo científico publicado en 2011

Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma.

artículo científico publicado en 2015

Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients

artículo científico publicado en 2005

Folinic acid does improve 5-fluorouracil activity in vivo. Results of a phase III study comparing 5-fluorouracil to 5-fluorouracil and folinic acid in advanced colon cancer patients

artículo científico publicado en 1993

From the Zeno's paradoxes to novel immunotherapeutic agents for kidney cancer: moving from an era of wrong premises and conclusions to a better comprehension of immunology

artículo científico publicado en 2013

Gemcitabine and oxaliplatin in the treatment of patients with immunotherapy-resistant advanced renal cell carcinoma: final results of a single-institution Phase II study.

artículo científico publicado en 2004

Granulocyte dysplasia and dysfunction, and CD11/CD18 defects in myelodysplastic syndromes

artículo científico publicado en 1996

HLA-A, B, C, DR and DQ expression and hepatocellular carcinoma: study of 205 Italian subjects

artículo científico publicado en 1995

High-dose human immunoglobulins in thrombotic thrombocytopenic purpura

artículo científico publicado en 1994

How to identify active novel agents in rare cancers and then make them available: a need for a paradigm shift

artículo científico publicado en 2012

Human mesothelioma cells exhibit tumor cell-specific differences in phosphatidylinositol 3-kinase/AKT activity that predict the efficacy of Onconase.

artículo científico publicado en 2005

Hypocholesterolemia and acute myeloid leukemia (AML)

artículo científico publicado en 1991

Hypokalemic rhabdomyolysis and thiazide diuretics. 3 clinical cases

artículo científico publicado en 1995

Imatinib mesylate enhances therapeutic effects of gemcitabine in human malignant mesothelioma xenografts

artículo científico publicado en 2008

Immunological effects of multikinase inhibitors for kidney cancer: a clue for integration with cellular therapies?

artículo científico publicado en 2011

Immunological stress in kidney cancer patients undergoing either open nephrectomy or nephron-sparing surgery: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cells.

artículo científico publicado en 2008

Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma

scientific article published on 01 July 2020

Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: a medical chart review across ten centers in five European countries

artículo científico publicado en 2014

Impact of topotecan-based chemotherapy on the immune system of advanced ovarian cancer patients: an immunophenotypic study

artículo científico publicado en 2002

Impaired bone marrow hematopoietic progenitor cell function in rheumatoid arthritis patients candidated to autologous hematopoietic stem cell transplantation

scientific article published on 01 April 2004

In vitro antioxidant properties of amifostine (WR-2721, Ethyol)

artículo científico publicado en 2000

Inadequacy of combined 5-Fluorouracil, very-high-dose leucovorin, mitomycin-C and Cisplatin as 2nd-line therapy for advanced colon-cancer

artículo científico publicado en 1995

Increased serum lipase with associated normoamylasemia in cancer patients

artículo científico publicado en 1998

Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy.

artículo científico publicado en 2011

Interleukin-2 induces cell cycle perturbations leading to cell growth inhibition and death in malignant mesothelioma cells in vitro

scientific article published on 01 October 2000

Intrahepatic fluorodeoxyuridine to treat unresectable hepatocellular carcinoma patients

artículo científico publicado en 1997

Intrapleural interleukin-2 induces nitric oxide production in pleural effusions from malignant mesothelioma: a possible mechanism of interleukin-2-mediated cytotoxicity?

artículo científico publicado en 2002

Intravenous prostacyclin (as epoprostenol) infusion in thrombotic thrombocytopenic purpura. Four case reports and review of the literature. Italian Cooperative Group for Thrombotic Thrombocytopenic Purpura.

artículo científico publicado en 1994

Is immunotherapy re-entering the kidney cancer arena from the back door? Considerations from the Phase I/II study of siltuximab

scientific article published on 01 April 2011

Jaw bone metastasis from hepatocellular carcinoma

scientific article published on 01 October 1997

Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor.

artículo científico publicado en 2003

Lack of evidence of antineutrophil cytoplasmic antibodies involvement in the acute phase of thrombotic thrombocytopenic purpura. Italian Cooperative Group for TTP

artículo científico publicado en 1996

Large Extracellular Vesicles-A New Frontier of Liquid Biopsy in Oncology

scientific article published on 07 September 2020

Left ventricular function in colon cancer patients receiving adjuvant fluoro-folate chemotherapy: an echocardiographic study

artículo científico publicado en 2000

Lingual metastasis from renal cell carcinoma: a case report and literature review

artículo científico

Long-term safety of sorafenib in advanced renal cell carcinoma: follow-up of patients from phase III TARGET.

artículo científico publicado en 2010

Low doses of alpha 2B interferon in the treatment of hairy cell leukemia: results of treatment and mean follow-up at 18 months in 13 patients

scientific article published on 01 February 1994

Low doses of subcutaneous interleukin-2 plus interferon-alpha do not induce thyroid function alterations in advanced renal cell carcinoma patients

artículo científico publicado en 2004

Malignant mesothelioma in 2004: How advanced technology and new drugs are changing the perspectives of mesothelioma patients. Highlights from the VIIth Meeting of the International Mesothelioma Interest Group.

artículo científico publicado en 2005

Malignant peritoneal mesothelioma: a multicenter study on 81 cases.

artículo científico publicado en 2009

Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma.

artículo científico publicado en 2011

Management of tyrosine kinase inhibitor-induced hand-foot skin reaction: viewpoints from the medical oncologist, dermatologist, and oncology nurse

scientific article published on January 2011

Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents: an expert agreement

artículo científico publicado en 2011

Medical treatment of unresectable hepatocellular carcinoma: Going beyond sorafenib

scientific article published on March 2010

Metachronous occurrence of seminoma and Hodgkin's lymphoma in the same patient with late-onset colon cancer

scientific article published on 01 July 1994

Metastatic renal cell carcinoma: how to make the best sequencing decision after withdrawal for intolerance to a tyrosine kinase inhibitor.

artículo científico publicado en 2013

Methimazole agranulocytosis treated with recombinant human granulocyte colony stimulating factor

scientific article published on 01 June 1995

Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors

artículo científico publicado en 2014

Multidisciplinary management of metastatic renal cell carcinoma in the era of targeted therapies

scientific article published on April 2012

Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey

artículo científico publicado en 2013

Negative results of an Italian Group for Mesothelioma (G.I.Me.) pilot study of single-agent imatinib mesylate in malignant pleural mesothelioma

artículo científico publicado en 2006

Nephrectomy as a component of systemic treatment for renal cell carcinoma patients

artículo científico publicado en 1994

New agents in the management of advanced mesothelioma.

artículo científico publicado en 2005

Nitrate plasma level as a marker of nitric oxide production after subcutaneous interleukin 2 immunotherapy.

artículo científico publicado en 1997

Nitrite and nitrate plasma levels, as markers of nitric oxide synthesis, in antiphospholipid antibodies-related conditions and in thrombotic thrombocytopenic purpura

scientific article published on 01 August 1997

Nitrite/nitrate balance during photoinduced cerebral ischemia in the rat determined by high-performance liquid chromatography with UV and electrochemical detection

artículo científico publicado en 1998

Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial

artículo científico publicado en 2020

Ocular involvement in acute thrombotic thrombocytopenic purpura.

artículo científico publicado en 1995

Optimizing further treatment choices in short- and long-term responders to first-line therapy for patients with advanced renal cell carcinoma

artículo científico

Optimizing treatment for metastatic renal cell carcinoma

artículo científico

Orai1 and transient receptor potential channels as novel molecular targets to impair tumor neovascularization in renal cell carcinoma and other malignancies

artículo científico

Osteonecrosis of the Jaw in Patients With Metastatic Renal Cell Cancer Treated With Bisphosphonates and Targeted Agents: Results of an Italian Multicenter Study and Review of the Literature.

artículo científico publicado en 2014

Outcomes from second-line therapy in long-term responders to first-line tyrosine kinase inhibitor in clear-cell metastatic renal cell carcinoma.

artículo científico publicado en 2014

Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trial

artículo científico

PD-1 blockade therapy in renal cell carcinoma: current studies and future promises.

artículo científico publicado en 2015

Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin.

artículo científico publicado en 2007

Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-alpha for metastatic renal cell cancer.

artículo científico publicado en 2009

Phosphatidylinositol-3-kinase/Akt signaling pathway and kidney cancer, and the therapeutic potential of phosphatidylinositol-3-kinase/Akt inhibitors

artículo científico publicado en 2009

Plasma and urinary endothelin-1 titers and plasma von Willebrand activity in Pseudoxanthoma elasticum

artículo científico publicado en 1998

Platelet agonists and calcium homeostasis in endothelial cells: possible role in the interaction of endothelium with hemostatic system

artículo científico publicado en 1998

Possible efficacy of allopurinol vaginal washings in the treatment of chemotherapy-induced vaginitis

scientific article published on 01 January 1998

Predictive value of baseline serum vascular endothelial growth factor and neutrophil gelatinase-associated lipocalin in advanced kidney cancer patients receiving sunitinib

artículo científico publicado en 2010

Preliminary data suggestive of a novel translational approach to mesothelioma treatment: imatinib mesylate with gemcitabine or pemetrexed

artículo científico publicado en 2007

Primary resistance to tyrosine kinase inhibitors in patients with advanced renal cell carcinoma: state-of-the-science.

artículo científico publicado en 2012

Pro-neoangiogenic cytokines (VEGF and bFGF) and anemia in solid tumor patients

scientific article published on 01 April 2005

Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy

artículo científico publicado en 2015

Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis.

artículo científico publicado en 2014

Raltitrexed-Oxaliplatin combination chemotherapy is inactive as second-line treatment for malignant pleural mesothelioma patients.

artículo científico publicado en 2005

Re: damien pouessel, stéphane culine. High frequency of intracerebral hemorrhage in metastatic renal carcinoma patients with brain metastases treated with tyrosine kinase inhibitors targeting the vascular endothelial growth factor receptor. Eur urol

artículo científico publicado en 2007

Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors

scientific article published on 30 December 2019

Rebuttal to: The usefulness of compression ultrasonography of the lower limbs in patients with a clinical suspicion of pulmonary embolism

artículo científico publicado en 2001

Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients

artículo científico publicado en 2011

Recombinant human interleukin-11 (Neumega, rhIL-11) reduces thrombocytopenia in breast cancer patients receiving tandem autologous circulating progenitor cell transportation

artículo científico publicado en 2002

Regarding: 'Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-alpha2a compared with sunitinib'.

artículo científico publicado en 2010

Regulation of CD4(+)NKG2D(+) Th1 cells in patients with metastatic melanoma treated with sorafenib: role of IL-15Rα and NKG2D triggering

artículo científico publicado en 2013

Renal cell carcinoma-induced immunosuppression: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cells

artículo científico publicado en 2007

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

artículo científico publicado en 2014

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Renal effects of targeted anticancer therapies

artículo científico publicado en 2015

Reply to S. Barni et Al and M. Sun et Al

artículo científico publicado en 2014

Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma

artículo científico publicado en 2012

Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol

artículo científico publicado en 2003

Rhe irreplaceable image: Superficial thrombosis of a varicose vein of the abdominal wall as the first sign of an otherwise occult locally-advanced ovarian cancer

scientific article published on 01 October 2001

SV40-dependent AKT activity drives mesothelial cell transformation after asbestos exposure.

artículo científico publicado en 2005

Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial

artículo científico publicado en 2009

Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trial.

artículo científico publicado en 2015

Safety and treatment patterns of multikinase inhibitors in patients with metastatic renal cell carcinoma at a tertiary oncology center in Italy ⬇️

artículo científico publicado el 24 de marzo de 2011

Safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma: a systematic review and meta-analysis

artículo científico publicado en 2020

Sarcoidosis following beta-interferon therapy for multiple myeloma

artículo científico publicado en 1995

Scrotal angiokeratoma (Fordyce): histopathological and ultrastructural findings

artículo científico publicado en 1992

Sequential intrahepatic and systemic fluoropyrimidine-based chemotherapy for metastatic colorectal cancer confined to the liver. A phase II study

artículo científico publicado en 2001

Sequential targeted therapy after pazopanib therapy in patients with metastatic renal cell cancer: efficacy and toxicity

artículo científico publicado en 2014

Sequential therapy in metastatic renal cell carcinoma: what comes next?

artículo científico publicado en 2012

Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases

article

Sigmoid colon metastasis from sarcomatoid renal cell carcinoma.

artículo científico publicado en 2006

Slow and steady wins the race: practical (and philosophical) considerations of treatment activity evaluation when novel anticancer agents just slow neoplastic progression

artículo científico publicado en 2013

Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma

scientific article published on 25 November 2020

Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting

artículo científico publicado en 2014

Sorafenib in advanced hepatocellular carcinoma

artículo científico publicado en 2008

Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis

article

Sorafenib plus daily low-dose temozolomide for relapsed glioblastoma: a phase II study.

artículo científico publicado en 2013

Sorafenib rechalenge in metastatic renal cell carcinoma

artículo científico publicado en 2012

Sorafenib tosylate in advanced kidney cancer: past, present and future

scientific article published on July 2009

Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial

artículo científico publicado en 2011

Steroids in prostate cancer: the jury is still out... and even more confused

artículo científico publicado en 2014

Store-operated Ca2+ entry does not control proliferation in primary cultures of human metastatic renal cellular carcinoma.

artículo científico publicado en 2014

Store-operated Ca2+ entry is remodelled and controls in vitro angiogenesis in endothelial progenitor cells isolated from tumoral patients

artículo científico publicado en 2012

Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: a single institution retrospective study.

artículo científico publicado en 2012

Sunitinib in metastatic renal cell carcinoma patients with brain metastases.

artículo científico publicado en 2010

Sunitinib re-challenge in advanced renal-cell carcinoma

artículo científico publicado en 2014

Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma

artículo científico publicado en 2014

Surgery and target agents for renal cell carcinoma treatment: the path between proper interaction

artículo científico publicado en 2011

Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors

artículo científico publicado en 2014

Targeting PI3K/Akt/mTOR Signaling in Cancer

artículo científico

Taurolidine and oxidative stress: a rationale for local treatment of mesothelioma

artículo científico publicado en 2009

The European Multidisciplinary Cancer Congress (ECCO 16, ESMO 36 and ESTRO 30) ⬇️

artículo científico publicado el 1 de enero de 2012

The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: a new pharmacodynamic marker?

artículo científico publicado en 2015

The clinical potential of temsirolimus in second or later lines of treatment for metastatic renal cell carcinoma

artículo científico

The effect of sorafenib treatment on the diabetic status of patients with renal cell or hepatocellular carcinoma

artículo científico publicado en 2012

The impact of antithrombotic prophylaxis on infectious complications in cancer patients with central venous catheters: an observational study.

artículo científico publicado en 2009

The infusion of high-dose immunoglobulins in a case of idiopathic thrombocytopenic purpura

artículo científico publicado el 1 de septiembre de 1992

The presence of simian-virus 40 sequences in mesothelioma and mesothelial cells is associated with high levels of vascular endothelial growth factor

artículo científico publicado en 2002

The role of the cell-cell interactions in cancer progression

artículo científico publicado en 2015

The treating scenario in genitourinary oncology: what is new? Part 1.

artículo científico publicado en 2013

The treating scenario in genitourinary oncology: what is new? Part 2.

artículo científico publicado en 2013

Thrombosis-related complications and mortality in cancer patients with central venous devices: an observational study on the effect of antithrombotic prophylaxis

artículo científico publicado en 2006

Thrombotic thrombocytopenic purpura and autoimmunity: a tale of shadows and suspects.

artículo científico publicado en 1999

Thrombotic thrombocytopenic purpura in systemic lupus erythematosus. Italian Cooperative Group for TTP

artículo científico publicado en 1993

Thrombotic thrombocytopenic purpura resistant to plasma-exchange: salvage treatment with high-dose IgG or vincristine. Italian Cooperative Group for TTP.

artículo científico publicado en 1993

Tivantinib (ARQ197) in hepatocellular carcinoma

artículo científico publicado en 2015

Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study.

artículo científico publicado en 2012

Tivantinib, a new option for second-line treatment of advanced hepatocellular carcinoma? The experience of Italian centers.

artículo científico publicado en 2015

Tolerability of first-line therapy for metastatic renal cell carcinoma

artículo científico publicado en 2009

Toxicities of targeted therapy and their management in kidney cancer.

artículo científico publicado en 2011

Transforming growth factor-beta released by PPD-presenting malignant mesothelioma cells inhibits interferon-gamma synthesis by an anti-PPD CD4+ T-cell clone

artículo científico publicado en 2003

Treating the individual: The need for a patient-focused approach to the management of renal cell carcinoma

artículo científico publicado en 2009

Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centre

artículo científico publicado en 2011

Treatment of thrombotic thrombocytopenic purpura with high-dose immunoglobulins. Results in 17 patients. Italian Cooperative Group for TTP ⬇️

artículo científico publicado el 1 de julio de 1995

Treatment selection in metastatic renal cell carcinoma: expert consensus

artículo científico publicado en 2012

Uncovering Pandora's vase: the growing problem of new toxicities from novel anticancer agents. The case of sorafenib and sunitinib.

artículo científico publicado en 2007

Use of a natural multicomponent mouthwash plus oral hygiene vs oral hygiene alone to prevent everolimus-induced stomatitis: the STOP multicenter, randomized trial

scientific article published on 03 May 2020

Use of sorafenib in two metastatic renal cell cancer patients with end-stage renal impairment undergoing replacement hemodialysis.

artículo científico publicado en 2009

Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey

artículo científico publicado en 2012

Utility of embolization of chemoembolization as second-line treatment in patients with advanced or recurrent colorectal carcinoma

scientific article published on 01 June 1995

Verapamil inhibits to different extents agonist-induced Ca2+ transients in human tumor cells and in vitro tumor cell growth

artículo científico publicado en 1996

Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma-exchange. The Italian Cooperative Group for TTP.

artículo científico publicado en 1994

[Eosinophilic infiltration of the gastrointestinal system: description of a clinical case simulating a lymphoproliferative process]

artículo científico publicado en 1990

[The diagnostic difficulties in a case of Behçet's disease]

artículo científico publicado en 1993

Eficacia de everolimus en el carcinoma avanzado de células renales: ensayo de fase III, doble ciego, aleatorizado y controlado con placebo

artículo científico publicado en 2008

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda